| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000021077 |
| Receipt No. | R000023967 |
| Official scientific title of the study | Examination of the change of the aqueous humor spillage before and after the glaucoma treatment |
| Date of disclosure of the study information | 2016/02/17 |
| Last modified on | 2016/06/02 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Examination of the change of the aqueous humor spillage before and after the glaucoma treatment | |
| Title of the study (Brief title) | Examination of the change of the aqueous humor spillage before and after the glaucoma treatment | |
| Region |
|
|
| Condition | ||
| Condition | Glaucoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | evaluate |
| Basic objectives2 | Others |
| Basic objectives -Others | study of |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | check |
| Key secondary outcomes | intraocular pressure |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | in patients with glaucoma,who have eye drop or operation | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | glaucoma patients | |||
| Key exclusion criteria | LASIK
injured |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Chin Shinki |
| Organization | Hokkaido University Graduate School of Medicine |
| Division name | Department of ophthalmology |
| Address | N-15, W-7, Kita-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-704-5944 |
| schin@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Kasumi Kikuchi |
| Organization | Hokkaido University Graduate School of Medicine |
| Division name | Department of Ophthalmology |
| Address | N-15, W-7, Kita-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-704-5944 |
| Homepage URL | |
| kakikuchi-spr@umin.ac.jp | |
| Sponsor | |
| Institute | Department of Ophthalmology Hokkaido University Graduate School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Ophthalmology Hokkaido University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | no results |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023967 |